| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |